12/7/2007

The FDA has given Indian generic drugmaker Ranbaxy Laboratories Ltd. tentative approval to market 5-mg and 10-mg tablets of donepezil hydrochloride, a version of Eisai Co. Ltd.'s Alzheimer's treatment Aricept. The Japanese drugmaker's U.S. patent for the drug expires in 2010.

Full Story:
Bloomberg

Related Summaries